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Background Pain is a common adverse effect of dermatological laser procedures.
Currently, no standard topical anaesthetic cream exists for deeper dermal laser
procedures.
Objectives To compare the efficacy of lidocaine/tetracaine cream and lidocaine/
prilocaine cream in reducing self-reported pain during deeper dermal laser treat-
ment of acne keloidalis nuchae (AKN) and tattoos.
Methods We conducted two randomized, double-blind, controlled clinical trials
with intrapatient, split-lesion designs: study A included patients with AKN
(n = 15); study B included patients with black tattoos (n = 15). The primary end
point was the patients’ self-reported pain on a 10-cm visual analogue scale
(VAS). Secondary objectives were the percentage of patients with adequate pain
relief, willingness to pay €25 for the cream that provided the best pain relief and
safety of the creams.
Results In both studies, VAS scores were lower for lidocaine/prilocaine cream,
with a mean VAS difference in study A of 19 [95% confidence interval (CI)
10–28] and in study B of 06 (95% CI 07 to 19). In study A, adequate pain
relief was achieved in 13% (n = 2) with lidocaine/tetracaine cream vs. 73%
(n = 11) with lidocaine/prilocaine cream (P = 0004), and in study B in 53%
(n = 8) vs. 80% (n = 12), respectively (P = 0289). In study A, 47% (n = 7)
were willing to pay an additional €25 vs. 73% (n = 11) in study B. No serious
adverse events occurred.
Conclusions Lidocaine/prilocaine cream under plastic occlusion is the preferred
topical anaesthetic during painful laser procedures targeting dermal
chromophores.
What’s already known about this topic?
• Pain is a common adverse effect during dermatological laser procedures, which can
be alleviated using a topical anaesthetic cream.
What does this study add?
• Lidocaine/tetracaine self-occlusive cream was not superior to lidocaine/prilocaine
cream under plastic occlusion in reducing self-reported pain during laser treatment
of acne keloidalis nuchae and tattoo removal.
• Lidocaine/prilocaine cream under occlusion is the preferred topical anaesthetic dur-
ing laser procedures when targeting dermal chromophores.
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Pain is a common and bothersome adverse effect of derma-
tological laser procedures. To prevent thermal damage to
the epidermis and to alleviate laser-induced pain, most laser
devices use simultaneous local skin cooling. However, local
cooling often does not provide adequate pain relief. In such
cases, local anaesthetics can be used to reduce
procedure-related pain and increase patient satisfaction.
Anaesthetics inhibit the sensory input to the central nervous
system by blocking voltage-gated sodium channels.1 The
blockade of sodium influx prevents action potentials and
inhibits nerve cell depolarization. B fibres (myelinated auto-
nomic preganglionic fibres) are blocked first, followed by C
fibres (nonmyelinated fibres) and, finally, A fibres (myeli-
nated somatic fibres), which regulate pain and tempera-
ture.2,3
Injectable anaesthetics can be painful to administer and
cannot be used in patients with needle phobia. Topical
anaesthetics may be an alternative option. One of the most
widely used products is an eutectic mixture of 25% lido-
caine and 25% prilocaine cream (EMLA, AstraZeneca, Lon-
don, U.K.; henceforth referred to as ‘LP cream’). A practical
disadvantage of LP cream is the need for it to be applied
under plastic occlusion. A recently (re)introduced topical
anaesthetic, which contains the highest concentration of
active anaesthetic ingredients available in a Food and Drug
Administration-approved topical cream, is an eutectic mixture
of 7% lidocaine and 7% tetracaine cream (Pliaglis,
Galderma Laboratories, Fort Worth, TX, U.S.A.; henceforth
referred to as ‘LT cream’). As LT cream forms a self-
occlusive film when exposed to air, it is said to not require
plastic occlusion. LT cream has shown superiority over pla-
cebo in pain reduction during several dermatological laser
procedures,4–7 and lower pain scores compared with LP
cream during (superficial) single-pass CO2 laser skin resurfac-
ing.8 However, apart from this single study, no head-to-head
studies have been performed for other dermatological indica-
tions or laser systems. It is therefore unknown whether LT
cream is also superior to LP cream in providing anaesthesia
when targeting dermal chromophores.
Two examples of common indications for laser treatment
in dermatology which require deeper dermal anaesthesia are
hair removal, such as in acne keloidalis nuchae (AKN), and
tattoo removal. AKN is a chronic, scarring folliculitis in
which hair follicles are the principle contributors to
inflammation.9 Laser-assisted hair removal causes coagulation
necrosis of the viable hair follicles and hair shafts in
the deep dermis, and has shown positive results for
AKN.10,11 In tattoos, using nanosecond Q-switched laser
pulses, the ink particles are fragmented into smaller pieces,
which can then be phagocytosed by macrophages and
cleared from the skin via the lymph vessels to the draining
lymph nodes.12
The aim of this study was to evaluate the efficacy of
LT cream compared with LP cream in reducing self-reported




Eligible for inclusion in study A were patients aged ≥ 18 years
with AKN, and eligible for inclusion in study B were those
aged ≥ 18 years with a black, professionally placed tattoo. Key
exclusion criteria for both studies included known hypersensi-
tivity or contact allergy to any components of the test materi-
als, use of any other pain medication 24 h prior to the study
visit, pregnant or breastfeeding women, and damaged skin at
the designated treatment area.
Study design and randomization
These double-blind, randomized, controlled trials with intrap-
atient, split-lesion design were approved by the medical
ethical review board of the Erasmus Medical Centre (MEC-
2014-517; 14-11-2014) and registered at ClinicalTrials.gov
(NCT02372786). All patients provided written informed con-
sent before study participation. Both studies were of single-
centre design and all patients were treated at the Erasmus
University Medical Centre in Rotterdam, the Netherlands.
Study design and treatment protocols were similar for both
studies. The treatment areas (i.e. necks in study A, and tattoos
in study B) were divided into two equal, anatomically similar
treatment sides (left and right). Both sides were separated by
an area of 1 cm, which was left untreated, to avoid possible
spill over effects of the two anaesthetic creams. Both creams
were applied to each patient, and the order of cream applica-
tion was randomized. A computer-generated randomization
list was provided by the department of Biostatistics of the
Erasmus Medical Centre, and was only available to the
unblinded study nurse. The creams were applied by our
unblinded study nurse according to the manufacturer’s
instructions and according to randomization. LT cream dried
when exposed to air (self-occlusive), and LP cream was
applied under occlusion using an occlusive plastic film
(Fig. 1). The creams were removed by the unblinded study
Fig 1. Application of lidocaine/tetracaine (LT) cream (self-occluding)
on the left treatment side and lidocaine/prilocaine (LP) cream under
plastic occlusion on the right treatment side in a patient with acne
keloidalis nuchae.
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nurse after 60 min, after which the patient was transferred to
the laser treatment room. The skin was then examined by the
blinded investigator and any local reactions were recorded. All
laser procedures were started within 5 min of removal of the
anaesthetic creams. In all cases, the laser treatment began on
the left treatment side followed by the right treatment side, to
minimize any potential order effect. Immediately after laser
treatment of each side, pain scores were assessed using a stan-
dard 10-cm visual analogue scale (VAS), with lower scores
indicating less pain.
One week after the visit, all patients were contacted
by telephone, to assess potential adverse events after
treatment.
Laser treatment
Laser settings were determined based on the safe clinical
responses to previously performed test spots. Test spots are
part of the normal routine procedure in our daily clinical
practice, and were executed before study participation.
Study A (acne keloidalis nuchae)
The neodymium-doped yttrium aluminum garnet (Nd:YAG)
laser (Cynosure Cynergy, Westford, MA, U.S.A.) emitting a
wavelength of 1064 nm was used for hair removal in patients
with AKN. A spot size of 7 or 10 mm, fluences of between
35 and 60 J/cm2, pulse duration of 25 ms and frequency of
1 Hz were used. Two passes were applied. Standardized air-
cooling (Zimmer Air Cooler; Zimmer, Irvine, CA, U.S.A.) was
administered during treatment for thermal protection of the
epidermis, and additional pain relief, whereby both sides were
(pre)cooled in an identical manner.
Study B (tattoos)
A Q-switched Nd:YAG laser (Quanta Systems, Solbiate Olona,
Italy), emitting a wavelength of 1064 nm was used for tattoo
removal. A spot size of 3 mm, fluences of between 6 and
10 J/cm2 and a frequency of 1 Hz were used. A single pass
was applied.
Study objectives
The primary objective of both studies was to compare the
efficacy of LT cream and LP cream in reducing self-reported
pain, using a 10-cm VAS, during a single laser procedure.
Secondary objectives of both studies were to evaluate the
percentage of patients who reported adequate pain relief
(yes/no), to monitor the nature and frequency of adverse
events, and to evaluate if patients were willing to pay
approximately €25 for the treatment that provided superior
pain reduction. This last question was included as LP cream
is, in the Netherlands, reimbursed by health insurance and
LT cream has to be purchased for approximately €25 (per
15 g).
Statistical analysis
For both studies, a sample size of 15 patients was calculated
to provide 80% power to detect a difference of 2 (SD 25) in
the VAS, which is determined to be (approximately) the mini-
mal clinically important difference that a patient can detect,13
with a two-sided type I error level of 5%. A t-test for paired
samples was used.
The results of the two studies were analysed separately. The
differences in VAS scores between the LT and LP creams were
analysed using a t-test for paired samples. Normality of the
variables was tested using a Shapiro–Wilk test. The differences
between LT and LP cream regarding adequate pain relief were
analysed using a McNemar test. The side on which the treat-
ment was least painful and willingness to spend approximately
€25 for the cream used on this side are shown as percentages
and absolute numbers of cases. P-values < 005 were consid-
ered statistically significant. SPSS Statistics 21 (IBM, Armonk,
NY, U.S.A.) was used for all analyses.
Results
Between February and September 2015, a total of 15 patients
were enrolled in study A (AKN), and between February and
July 2015, a total of 15 patients were enrolled in study B (tat-
toos). Patient demographics are shown in Table 1. There were
no dropouts or exclusions after randomization in both studies.









Mean  SD age (years) 41  12 39  10







Previous laser treatments (n%)
No 15 (100) 7 (47)








Upper extremities – 10
Lower extremities – 2
AKN, acne keloidalis nuchae.
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Study A: acne keloidalis nuchae
The mean  SD VAS scores were 55  17 for LT cream and
37  26 for LP cream (Fig. 2), with a mean VAS difference
of 19 [95% confidence interval (CI) 10–28; P = 0001].
Adequate pain relief during the laser procedure was
achieved in 13% (n = 2) of the patients receiving LT cream
and 73% (n = 11) of the patients receiving LP cream
(P = 0004) (Fig. 3).
Seven per cent (n = 1) rated the side treated with LT cream
as least painful vs. 80% (n = 12) of the patients receiving LP
cream. Thirteen per cent (n = 2) of the patients did not have
a preference for either side. Of all patients, 47% (n = 7) were
willing to pay €25 for future treatment with the cream that
provided the best pain relief.
Study B: tattoos
The mean  SD VAS scores were 43  18 for LT cream and
37  23 for LP cream (Fig. 4). The mean VAS difference of
06 (95% CI 07 to 19; P = 0335) was not statistically
significant.
Adequate pain relief during the laser procedure was achieved
in 53% (n = 8) of the patients with LT cream and 80% (n = 12)
of the patients with LP cream (P = 0289) (Fig. 5).
Of all patients, 33% (n = 5) rated the side treated with LT
cream as least painful vs. 60% (n = 9) of the patients for LP
cream. Seven per cent (n = 1) of the patients did not have a
preference for either side. Of all patients, 73% (n = 11) were
willing to pay €25 for future treatment with the cream that
provided the best pain relief.
Local reactions and adverse events of both studies
During examination of the skin immediately after cream
removal, the side treated with LT cream showed blanching in
0%, oedema in 20% (n = 3) and erythema in 27% (n = 4) in
Fig 2. Study A: patients with acne keloidalis nuchae (n = 15). Visual
analogue scale scores after application of lidocaine/tetracaine (LT)
cream (self-occluding) on one treatment side and lidocaine/prilocaine
(LP) cream under plastic occlusion on the other treatment side
(P = 0001).
Fig 3. Study A: patients with acne keloidalis nuchae (n = 15).
Percentage of patients who perceived adequate pain relief after
application of lidocaine/tetracaine (LT) cream (self-occluding) on one
treatment side and lidocaine/prilocaine (LP) cream under plastic
occlusion on the other treatment side (P < 0004).
Fig 4. Study B: patients with tattoos (n = 15). Visual analogue scale
scores after application of lidocaine/tetracaine (LT) cream (self-
occluding) on one treatment side and lidocaine/prilocaine (LP) cream
under plastic occlusion on the other treatment side (P = 0335).
Fig 5. Study B: patients with tattoos (n = 15). Percentage of patients
who perceived adequate pain relief after application of lidocaine/
tetracaine (LT) cream (self-occluding) on one treatment side and
lidocaine/prilocaine (LP) cream under plastic occlusion on the other
treatment side (P = 0289).
© 2016 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists
British Journal of Dermatology (2017) 176, pp81–86
84 Comparison of LT cream and LP cream, K. Greveling et al.
study A, and blanching in 0%, oedema in 13% (n = 2) and
erythema in 53% (n = 8) in study B. On the side treated with
LP cream no local reactions were seen after cream removal in
study A, and in study B blanching was seen in 47% (n = 7),
oedema in 7% (n = 1) and erythema in 0% of the patients.
These local reactions were all mild and transient.
Thirteen patients in study A and 13 in study B were avail-
able for telephone consultation 1 week after treatment. In
study A, two patients reported adverse events: burning sensa-
tion (n = 1), and itching and crusting (n = 1). In study B, five
patients reported adverse events: swelling (n = 1), itching
(n = 2) and mild blistering (n = 2). All adverse events were
transient and most likely related to the laser treatments. No
serious adverse events occurred.
Discussion
The main finding of study A was that LP cream provided sta-
tistically significant lower pain scores than LT cream during
the Nd:YAG laser treatment of AKN. Previous studies defined
the minimal clinically important difference (i.e. the smallest
clinically relevant change that a patient can detect) on a 100-
mm VAS to be between 9 and 18 mm.13,14 Thus, the statisti-
cally significant 19-mm VAS difference we found between the
two creams during AKN treatment (favouring LP cream) is
also clinically relevant.
The results of study B showed no significant differences
between the two creams in reducing self-reported pain during
the Q-switched Nd:YAG laser treatment of tattoos, although the
numerical difference appears to be in favour of LP cream. Possi-
bly, the lack of statistical significance in this study, compared
with study A, is caused by the fact that laser-assisted hair
removal in AKN is more painful than tattoo removal. Breivik
et al. showed that the power to detect a difference in pain inten-
sity is higher when there is a large difference and a higher base-
line pain.15,16 Terminal hair follicles are located deeper in the
dermis than tattoo ink particles and, together with the larger
spot size and higher fluence (causing more volumetric bulk
heating of the dermis), treatment with a long-pulsed Nd:YAG
laser for hair removal is associated with more (painful) thermal
injury to the skin than the ultrashort-pulsed Nd:YAG laser used
for tattoo removal. Also, in laser tattoo removal there is less of a
photothermal and more of a photoacoustic effect, which is less
painful. Additionally, the AKN group was very homogeneous,
whereas the tattoo group was more heterogeneous, including
various anatomical locations, sexes, skin types and number of
previous laser treatments. These are all factors that could have
increased the variability and therefore have influenced the statis-
tical significance of the results.
The results appear to be in contrast with the only published
head-to-head study which reported self-occluding LT cream to
be superior to LP cream under occlusion, after a 30-min applica-
tion time, during single-pass CO2 laser skin resurfacing.
8 How-
ever, it might not be possible to extrapolate the results found
during this superficial laser treatment to treatments with longer
wavelength lasers used for both AKN and tattoo removal. Longer
wavelength lasers penetrate much deeper into the dermis, trig-
gering far more nerves than a single-pass CO2 laser skin ablation.
Furthermore, as the label-recommended application time for LP
cream is a minimum of 60 min (https://www.medicines.
org.uk), the results of Alster and Lupton may have been influ-
enced by the shorter application time of only 30 min.8
The effectiveness of an anaesthetic cream mainly depends
on the rate of (trans)dermal absorption. This absorption rate
is determined by the thickness of the stratum corneum, and
the pKa (acid dissociation constant) of the anaesthetic.2 Pene-
tration through the skin can be enhanced by occlusion, which
increases temperature and hydration of the stratum corneum.
The thinner the stratum corneum and the closer the pKa
matches the pH of the skin (~55),17 the better the anaesthetic
penetrates through the skin. As every patient in both of our
studies was his or her own control, the thickness of the stra-
tum corneum was equal for both treatment sides. Both creams
contained lidocaine (pKa 77), and the pKa of prilocaine and
tetracaine did not differ substantially (79 and 86, respec-
tively).18 Therefore, the main factor that could have made a
difference in (trans)dermal absorption between the two
creams is the different method of occlusion. The flexible film
formed by LT cream might not have facilitated optimal drug
absorption and, despite its higher concentrations of anaesthet-
ics, provided less (deeper) dermal pain reduction.
Besides pain reduction, potential side-effects, costs and ease
of use should be taken into account when choosing an anaes-
thetic cream. Mild local reactions were observed after cream
removal, but no clinically important differences between the
two creams were evident. In the Netherlands, the retail price
of LT cream is approximately 25 times higher than that of LP
cream, and LT cream is not reimbursed by health insurance.
In our experience, LT cream was easier to apply but some-
times difficult to remove. On the contrary, LP cream was more
difficult to apply using plastic occlusion but easier to remove.
Limitations of both studies were the relatively small sample
sizes, and that patients were not completely blinded as the
methods of occlusion were different. However, it was assumed
patients did not know which method belonged to which cream.
In summary, we conclude that a 60-min application of LP
cream under plastic occlusion is the preferred topical
anaesthetic during painful laser procedures targeting dermal
chromophores.
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